— Know what they know.
Not Investment Advice

BBC

Virtus Biotech Clinical Trials ETF
1W: -1.3% 1M: -17.1% 3M: -15.6% YTD: +18.4% 1Y: +63.3% 3Y: +130.2% 5Y: -5.1%
$44.56
-0.44 (-0.98%)
 
Weekly Expected Move ±4.8%
$40 $42 $45 $47 $49
ETF AMEX · AUM $42.3M

Portfolio Health Summary

IS Overall Score
35.4
★★★★★
Altman Z-Score
25.58
Safe
Weight Coverage
96%
of portfolio analyzed
Holdings Matched
125
with fundamental data

InsiderStreet Scorecard

★★★★★ 35.4
Profitability
24.6
Balance Sheet
56.8
Earnings Quality
49.7
Growth
50.5
Value
35.6
Momentum
48.5
Safety
76.8

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
25.58
Safe Zone (>2.99)
Piotroski F-Score
2.9 / 9
Weak
Beneish M-Score
-74.30
Unlikely Manipulator
Credit Score
—
Earnings Quality
49.7 / 100

Portfolio Valuation

P/E
282.10x
P/B
5.44x
P/S
82.80x
EV/EBITDA
189.27x
EV/Revenue
78.99x
P/FCF
2556.16x
P/OCF
2389.13x
PEG
77.93x
Earnings Yield
0.35%
FCF Yield
0.04%
OCF Yield
0.04%
Median P/E
-6.63x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +46.1%
Net Income -17.5%
EPS +3.6%
FCF -20.1%
EBITDA -11.5%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +54.7%
Rev CAGR 5Y +26.6%
EPS CAGR 3Y —
EPS CAGR 5Y —
FCF CAGR 3Y —
FCF CAGR 5Y +27.5%
EBITDA CAGR 3Y —
EBITDA CAGR 5Y —
Payout Ratio
0.00%
Buyback Yield
0.29%
Dividend Yield
0.00%
Total Shareholder Return
-27.94%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$44.56
Median 1Y
$44.40
5th Pctile
$24.10
95th Pctile
$81.93
Ann. Volatility
39.6%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 282.10
Portfolio P/B 5.44
Portfolio P/S 82.80
EV/EBITDA 189.27
EV/Revenue 78.99
P/FCF 2556.16
P/OCF 2389.13
PEG 77.93
Earnings Yield 0.35%
FCF Yield 0.04%
OCF Yield 0.04%
Median P/E -6.63
Profitability & Returns (9)
MetricValue
Gross Margin 92.99%
Operating Margin -683.60%
Net Margin -629.31%
FCF Margin -672.83%
ROE -46.77%
ROA -36.15%
ROIC -183.87%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.12
Debt/Assets 0.09
Net Debt/EBITDA -31.89
Interest Coverage -43.73
Current Ratio 9.42
Quick Ratio 9.42
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 46.08%
Net Income Growth -17.51%
EPS Growth 3.62%
FCF Growth -20.11%
EBITDA Growth -11.46%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 54.68%
Revenue CAGR 5Y 26.64%
Revenue CAGR 10Y —
EPS CAGR 3Y —
EPS CAGR 5Y —
EPS CAGR 10Y —
FCF CAGR 3Y —
FCF CAGR 5Y 27.45%
FCF CAGR 10Y —
EBITDA CAGR 3Y —
EBITDA CAGR 5Y —
EBITDA CAGR 10Y —
Net Income CAGR 3Y —
Net Income CAGR 5Y —
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 35.4
IS Profitability 24.6
IS Balance Sheet 56.8
IS Earnings Quality 49.7
IS Growth 50.5
IS Value 35.6
IS Momentum 48.5
IS Safety 76.8
IS Quality 42.2
Altman Z-Score 25.58
Piotroski F-Score 2.86
Beneish M-Score -74.30
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.00%
Payout Ratio 0.00%
Buyback Yield 0.29%
Total Shareholder Return -27.94%
Growth Stability (4)
MetricValue
Revenue Stability 0.659
Earnings Stability 0.588
Earnings Persistence 0.745
Margin Stability 0.278
Medians (3)
MetricValue
Median P/E -6.63
Median P/B 3.44
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 95.80%
Holdings Matched 125
Total Holdings 129

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms